Technology-Based Psychosocial Empowerment Program for Home Care of Children With Cancer and Their Parents

April 25, 2023 updated by: Hazal Ozdemir Koyu, Gazi University

Efficiency of the Technology-Based Psychosocial Empowerment Program for Home Care of Children With Cancer and Their Parents

This research was planned to evaluate the effectiveness of the technology-based psychosocial empowerment program for home care for children aged 8-18 years with cancer and their parents as a parallel-group randomized controlled study design.The required institutional permission and ethics committee approval was received.The study group of the study consisted of 72 children and parents (intervention group [n=36], control group [n=36]). Data were collected using the descriptive features form, the General Self-Efficacy Scale-Pediatric Cancer Version, the State-Trait Anxiety Inventory for Children, the Pediatric Cancer Coping Scale, the General Self-Efficacy Scale for parents, the Problem Solving Inventory, and the Psychological Resilience Scale for Parents of Children with Cancer. The data were stored in the SPSS 25 program.

Study Overview

Status

Not yet recruiting

Detailed Description

The incidence of childhood cancers has become an important health problem increasing all over the world. Children and parents are affected in many dimensions physically, psychologically, and socially during this experience. The needs of the child and parents are not limited to the treatment period in the hospital. They also need to be supported and strengthened during the home care process. The required institutional permission and ethics committee approval was received. The study group of study consisted of 72 children and parents (intervention group [n=36], control group [n=36]).The technology-based program was applied to children and families for 4-6 weeks through modules on the website. In addition, at the end of each module, online interviews or telephone counseling will be applied.Children and parents in the control group will follow the standard care procedures included in the treatment process. At the end of the study, it was planned to apply website modules to the children and parents in the control group. The research is based on the Psychological Empowerment Theory.

Study Type

Interventional

Enrollment (Anticipated)

72

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • For children's:
  • Children between the ages of 8-18,
  • Those receiving cancer treatment (leukemias and solid tumors) and completing the first 2 months of the treatment process,
  • Children with tablets, android phones and internet access
  • Children whose parents and themselves agree to participate in the study,
  • Children who can continue the study for 4-6 weeks,
  • For primary care parents,
  • Parents who can speak Turkish,
  • Parents who can use computers and android mobile phones,
  • Parents who agreed to participate in the study,
  • Parents who can continue the study for 4-6 weeks,

Exclusion Criteria:

  • Newly diagnosed children (in induction phase),
  • Children who are in the terminal period or who are treated for relapse,
  • Presence of another important disease (such as chronic disease, psychiatric diagnosis) in the family that may prevent coping, other than the child followed up with the diagnosis of cancer

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group
-The experimental group that applied the technology-based psychosocial program
A technology-based model-based psychosocial empowerment program will be implemented for parents and children in the control group.
Other Names:
  • Technology-based psychosocial program
Other: Control group
Control group receiving standard care
Parents and children in the intervention group will be applied standard support approaches to be applied in the center where they receive treatment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
General Self-Efficacy Scale-Pediatric Cancer Version
Time Frame: Change from Baseline level 'Self Efficacy' to 2 months (change is being assessed)
It is a one-dimensional, 10-item scale used to evaluate self-efficacy in children aged 8-18 years with cancer.As the score obtained from the scale increases, the level of self-efficacy also increases.
Change from Baseline level 'Self Efficacy' to 2 months (change is being assessed)
Pediatric Cancer Coping Scale
Time Frame: Change from Baseline level 'Pediatric Cancer Coping Scale' to 2 months (change is being assessed)
It was developed to evaluate coping in children aged 7-18 years with cancer diagnosis. The scale consists of 3 sub-dimensions as cognitive coping, problem-focused coping and defensive coping. The higher the score, the higher the coping strategies.
Change from Baseline level 'Pediatric Cancer Coping Scale' to 2 months (change is being assessed)
General Self-Efficacy Scale
Time Frame: Change from Baseline level 'Self Efficacy' to 2 months (change is being assessed)
It is a one-dimensional scale developed to evaluate the general self-efficacy level of adults.As the score obtained from the scale increases, the level of self-efficacy also increases.
Change from Baseline level 'Self Efficacy' to 2 months (change is being assessed)
Problem Solving Inventory
Time Frame: Change from Baseline level 'Problem Solving Inventory' to 2 months (change is being assessed)
It is a scale that measures the problem solving skills of individuals according to the perception of the individual.The inventory consists of three sub-dimensions: Safe in Problem Solving, Approach Avoidance Style and Personal Control.Low scores from the inventory indicate the ability to produce effective solutions to problems, while high scores indicate the inability to find effective solutions to problems.
Change from Baseline level 'Problem Solving Inventory' to 2 months (change is being assessed)
State-Trait Anxiety Inventory for Children
Time Frame: Change from Baseline level 'State-Trait Anxiety' to 2 months (change is being assessed)
he 'State-Trait Anxiety Scale' for children between the ages of 8-18 was created to determine what the child feels at that moment, and the 'Stait-Trait Anxiety Scale' was created to determine what they usually feel. The higher the score, the higher the anxiety level.
Change from Baseline level 'State-Trait Anxiety' to 2 months (change is being assessed)
Psychological Resilience Scale for Parents of Children with Cancer
Time Frame: Change from Baseline level 'Psychological Resilience Scale for Parents of Children with Cancer'' to 2 months (change is being assessed)
The Resilience Scale for Parents of Children was developed to examine the resilience status of parents of children aged 0-18 years with cancer diagnosis. The scale consists of 24 items and 4 sub-dimensions. As the score obtained from the scale increases, the level of psychological resilience of the parents increases.
Change from Baseline level 'Psychological Resilience Scale for Parents of Children with Cancer'' to 2 months (change is being assessed)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SSPedi: Symptom Screening Scale in Pediatric Patients
Time Frame: While the intervention continues (1 months), the log records of the scale on the website will be evaluated.
The screening tool includes 15 symptoms that evaluate the symptoms children have experienced in the last two days. Each symptom is evaluated with a 5-point Likert-type scoring system, and the score range varies between 0-60. Higher scores indicate that the number of symptoms and the discomfort they cause increase
While the intervention continues (1 months), the log records of the scale on the website will be evaluated.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

September 1, 2023

Primary Completion (Anticipated)

September 1, 2024

Study Completion (Anticipated)

November 1, 2024

Study Registration Dates

First Submitted

September 23, 2022

First Submitted That Met QC Criteria

September 30, 2022

First Posted (Actual)

October 5, 2022

Study Record Updates

Last Update Posted (Actual)

April 27, 2023

Last Update Submitted That Met QC Criteria

April 25, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • Technology-Based Program

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

There are no plans to make individual participant data (IPD) available to other researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on Psychosocial program

3
Subscribe